CHRS logo

Coherus BioSciences (CHRS) Current Assets

Annual Current Assets

$475.63 M
+$94.40 M+24.76%

December 31, 2023


Summary


Performance

CHRS Current Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCHRSbalance sheetmetrics:

Quarterly Current Assets

$369.02 M
-$188.91 M-33.86%

September 30, 2024


Summary


Performance

CHRS Quarterly Current Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCHRSbalance sheetmetrics:

Current Assets Formula

Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets

CHRS Current Assets Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+24.8%-16.9%
3 y3 years-38.0%-4.3%
5 y5 years+463.3%-4.3%

CHRS Current Assets Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-21.0%+24.8%-41.2%+16.8%
5 y5-year-38.0%+38.7%-51.9%+16.8%
alltimeall time-38.0%+1817.9%-51.9%+707.9%

Coherus BioSciences Current Assets History

DateAnnualQuarterly
Sep 2024
-
$369.02 M(-33.9%)
Jun 2024
-
$557.93 M(-11.1%)
Mar 2024
-
$627.48 M(+31.9%)
Dec 2023
$153.97 M(+54.6%)
$475.63 M(+7.0%)
Sep 2023
-
$444.37 M(+15.3%)
Jun 2023
-
$385.48 M(+22.0%)
Mar 2023
-
$315.93 M(-17.1%)
Dec 2022
$99.61 M(+29.3%)
$381.23 M(-15.0%)
Sep 2022
-
$448.27 M(+0.3%)
Jun 2022
-
$446.78 M(-12.8%)
Mar 2022
-
$512.44 M(-14.9%)
Dec 2021
$77.01 M(+3.8%)
$602.32 M(-10.5%)
Sep 2021
-
$673.04 M(+2.0%)
Jun 2021
-
$660.01 M(+6.9%)
Mar 2021
-
$617.26 M(-19.6%)
Dec 2020
$74.17 M(+12.5%)
$767.48 M(+5.6%)
Sep 2020
-
$726.92 M(+7.6%)
Jun 2020
-
$675.86 M(+71.0%)
Mar 2020
-
$395.18 M(+15.2%)
Dec 2019
$65.92 M
$343.01 M(+24.1%)
Sep 2019
-
$276.38 M(+34.4%)
Jun 2019
-
$205.63 M(+29.2%)
DateAnnualQuarterly
Mar 2019
-
$159.16 M(+88.5%)
Dec 2018
$15.03 M(-12.3%)
$84.43 M(-35.2%)
Sep 2018
-
$130.31 M(-24.6%)
Jun 2018
-
$172.78 M(+53.9%)
Mar 2018
-
$112.24 M(-22.8%)
Dec 2017
$17.13 M(+0.8%)
$145.48 M(-15.2%)
Sep 2017
-
$171.60 M(+11.9%)
Jun 2017
-
$153.34 M(-26.4%)
Mar 2017
-
$208.26 M(+29.0%)
Dec 2016
$17.00 M(+13.3%)
$161.49 M(-8.9%)
Sep 2016
-
$177.32 M(-25.1%)
Jun 2016
-
$236.83 M(+11.9%)
Mar 2016
-
$211.58 M(+7.2%)
Dec 2015
$15.00 M(+85.5%)
$197.39 M(+4.3%)
Sep 2015
-
$189.30 M(-21.0%)
Jun 2015
-
$239.59 M(+66.5%)
Mar 2015
-
$143.90 M(-19.7%)
Dec 2014
$8.09 M(+356.8%)
$179.14 M(+50.7%)
Sep 2014
-
$118.88 M(+3.6%)
Jun 2014
-
$114.71 M(+151.1%)
Dec 2013
$1.77 M(+2.1%)
$45.68 M
Dec 2012
$1.73 M
-

FAQ

  • What is Coherus BioSciences annual total current assets?
  • What is the all time high annual current assets for Coherus BioSciences?
  • What is Coherus BioSciences annual current assets year-on-year change?
  • What is Coherus BioSciences quarterly total current assets?
  • What is the all time high quarterly current assets for Coherus BioSciences?
  • What is Coherus BioSciences quarterly current assets year-on-year change?

What is Coherus BioSciences annual total current assets?

The current annual current assets of CHRS is $475.63 M

What is the all time high annual current assets for Coherus BioSciences?

Coherus BioSciences all-time high annual total current assets is $767.48 M

What is Coherus BioSciences annual current assets year-on-year change?

Over the past year, CHRS annual total current assets has changed by +$94.40 M (+24.76%)

What is Coherus BioSciences quarterly total current assets?

The current quarterly current assets of CHRS is $369.02 M

What is the all time high quarterly current assets for Coherus BioSciences?

Coherus BioSciences all-time high quarterly total current assets is $767.48 M

What is Coherus BioSciences quarterly current assets year-on-year change?

Over the past year, CHRS quarterly total current assets has changed by -$75.34 M (-16.95%)